ToGA临床研究证实，曲妥珠单抗(赫赛汀)联合化疗可改善HER2阳性晚期胃癌患者的生存，患者联合用药的中位OS为

试卷相关题目

SQL Error: select id,body,options from ***_enewstiku where sourceid='29305' and id < 2385087 and id<>'2385087' order by id desc limit 5 SQL Error: select id,body,options from ***_enewstiku where sourceid='29305' and id > 2385087 and id<>'2385087' order by id asc limit 5